
Metropolis Healthcare’s revenue rose 17% year-on-year to Rs 450 crore in the June quarter of FY27, while net profit increased 26% to Rs 57 crore. The diagnostics chain is also expanding in…
Metropolis Healthcare’s revenue rose 17% year-on-year to Rs 450 crore in the June quarter of FY27, while net profit increased 26% to Rs 57 crore. The diagnostics chain is also expanding in smaller cities, where tier-III towns and beyond now account for 27-28% of its business and are growing at about 25-26%, Mint reports.
Metropolis added 70-75 laboratories in smaller towns over the past three years and established 90 labs serving about 750 towns. It is now focusing on network density through collection centres, partnerships with smaller laboratories and hospitals, while remaining open to acquisitions. Organised players account for about 15% of India’s diagnostics market, according to the company.
The easy story is that organised chains will simply replace local laboratories. Metropolis itself says they are also creating demand for specialised tests, but claims about unorganised providers losing ground rely partly on anecdotal vendor feedback. The opposite claim, that small-town expansion automatically means better access, is just as thin unless prices and test quality improve. Watch whether Metropolis can sustain 25% growth without making diagnostics less affordable.
Source: livemint.com
This story was synthesised by AI from the source linked above.